Profilo
Bruno Ohana is the founder of Biologit.
He held the title of Chief Technology Officer & Director at Biologit.
Posizioni attive di Bruno Ohana
| Società | Posizione | Inizio |
|---|---|---|
biologit
 biologit Packaged SoftwareTechnology Services Biologit is an Irish technology company that specializes in AI development and dataset labeling for safety surveillance. The company is based in Dublin, Ireland and was founded by Naveen Basar and Bruno Ohana. Biologit combines expertise in pharmacovigilance, pharmaceuticals, biomedical, and artificial intelligence to deliver solutions that unlock safety and efficacy information faster, without compromising on quality, with the goal to keep patients safe. The company's flagship product, Biologit MLM-AI, is a scientific literature monitoring tool for human and veterinary pharmacovigilance, cosmetovigilance, and medical devices powered by artificial intelligence. The tool helps pharmacovigilance professionals focus on screening articles that matter. Nicole Baker has been the CEO since incorporation. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
biologit
biologit Packaged SoftwareTechnology Services Biologit is an Irish technology company that specializes in AI development and dataset labeling for safety surveillance. The company is based in Dublin, Ireland and was founded by Naveen Basar and Bruno Ohana. Biologit combines expertise in pharmacovigilance, pharmaceuticals, biomedical, and artificial intelligence to deliver solutions that unlock safety and efficacy information faster, without compromising on quality, with the goal to keep patients safe. The company's flagship product, Biologit MLM-AI, is a scientific literature monitoring tool for human and veterinary pharmacovigilance, cosmetovigilance, and medical devices powered by artificial intelligence. The tool helps pharmacovigilance professionals focus on screening articles that matter. Nicole Baker has been the CEO since incorporation. | Technology Services |
- Borsa valori
- Insiders
- Bruno Ohana
